3rd Quarter - Report

PODESTA GROUP, INC. for AMGEN

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Economics/Economic Development ECN

Economic policy.

LobbyistCovered position, as disclosed
SHARON COHEN —
ISRAEL S KLEIN New Comm. Director, Sen. Charles Schumer

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Health Issues HCR

Prescription Drug User Fee Act reauthorization.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Medicare/Medicaid MMM

Medicare Part B reimbursement and coverage of dialysis products.

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —
OSCAR RAMIREZ —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Budget/Appropriations BUD

Prescription Drug User Fee Act reauthorization. FY 2011 funding in regards to the FDA. H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012

LobbyistCovered position, as disclosed
SHARON COHEN —
ANTHONY PODESTA —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2112 (112th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.